Only few promising antibiotics in pipeline, says ICAAC expert

Of the hundreds of posters at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy, only seven featur-ing preclinical antibiotics research worldwide were selected as worthy of mention by the ICAAC program committee in its annual poster summary. Of these, only two were called "outstanding" by expert Steven J. Projan, Ph.D., Wyeth research, who warned in a press briefing, "Fewer and fewer important antibiotics are being developed." Here are the two he recommended for special attention by ICAAC attendees: